📊 Does good-looking mean great for analysis?
In a new EASD e-Learning Expert Insights episode, #statistician Petra Baumann (@medunigraz.at) shares practical tips for organising your #CGM and #hbA1c #data tables to be truly analysis-ready.
📺 Watch here: easd-elearning.eu/episode/385/...
In a new EASD e-Learning Expert Insights episode, #statistician Petra Baumann (@medunigraz.at) shares practical tips for organising your #CGM and #hbA1c #data tables to be truly analysis-ready.
📺 Watch here: easd-elearning.eu/episode/385/...
November 4, 2026 at 1:35 PM
📊 Does good-looking mean great for analysis?
In a new EASD e-Learning Expert Insights episode, #statistician Petra Baumann (@medunigraz.at) shares practical tips for organising your #CGM and #hbA1c #data tables to be truly analysis-ready.
📺 Watch here: easd-elearning.eu/episode/385/...
In a new EASD e-Learning Expert Insights episode, #statistician Petra Baumann (@medunigraz.at) shares practical tips for organising your #CGM and #hbA1c #data tables to be truly analysis-ready.
📺 Watch here: easd-elearning.eu/episode/385/...
🎙️New #podcast episode! EASD TV Host Vivienne Parry speaks with Prof. Andreas Birkenfeld (Universitätsklinikum Tübingen), 2026 Camillo Golgi Prize recipient, about pre-diabetes remission, early detection and new approaches to preventing #type2diabetes.
🎧👉 Listen now: www.easd.org/media-centre...
🎧👉 Listen now: www.easd.org/media-centre...
November 6, 2026 at 1:22 PM
🎙️New #podcast episode! EASD TV Host Vivienne Parry speaks with Prof. Andreas Birkenfeld (Universitätsklinikum Tübingen), 2026 Camillo Golgi Prize recipient, about pre-diabetes remission, early detection and new approaches to preventing #type2diabetes.
🎧👉 Listen now: www.easd.org/media-centre...
🎧👉 Listen now: www.easd.org/media-centre...
🎥Missed a session at #EASD2026 or want to rewatch your favourite talks? Explore 1,000s of presentations, resources, recordings & e-posters from the 62nd EASD Annual Meeting in Milan - now available for free in our EASD Media Centre.
🔗👉 Explore the Media Centre: www.easd.org/media-centre/
#Diabetes
🔗👉 Explore the Media Centre: www.easd.org/media-centre/
#Diabetes
November 6, 2026 at 11:05 AM
🎥Missed a session at #EASD2026 or want to rewatch your favourite talks? Explore 1,000s of presentations, resources, recordings & e-posters from the 62nd EASD Annual Meeting in Milan - now available for free in our EASD Media Centre.
🔗👉 Explore the Media Centre: www.easd.org/media-centre/
#Diabetes
🔗👉 Explore the Media Centre: www.easd.org/media-centre/
#Diabetes
Applications for the 3rd EASD Diabetes Technology School are now open!
A 3-day course for HCPs to enhance their expertise in #diabetes #technology - from #CGM and #AID to digital health platforms.
📅 Deadline: 7 January 2027 |📍 Vienna, Austria
🔗👉 Apply now: www.easd.org/education/me...
A 3-day course for HCPs to enhance their expertise in #diabetes #technology - from #CGM and #AID to digital health platforms.
📅 Deadline: 7 January 2027 |📍 Vienna, Austria
🔗👉 Apply now: www.easd.org/education/me...
November 2, 2026 at 10:25 AM
Applications for the 3rd EASD Diabetes Technology School are now open!
A 3-day course for HCPs to enhance their expertise in #diabetes #technology - from #CGM and #AID to digital health platforms.
📅 Deadline: 7 January 2027 |📍 Vienna, Austria
🔗👉 Apply now: www.easd.org/education/me...
A 3-day course for HCPs to enhance their expertise in #diabetes #technology - from #CGM and #AID to digital health platforms.
📅 Deadline: 7 January 2027 |📍 Vienna, Austria
🔗👉 Apply now: www.easd.org/education/me...
🚀 Take your career in #diabetes #research to the next level with the EASD Early Career Academy Mentorship programme. Applications are open for the chance to connect, learn and advance your career with expert mentors.
🗓️ Deadline: 20 Nov 2026 | 🕛 12:00 CET
👉 Apply now: www.easd.org/academy/acad...
🗓️ Deadline: 20 Nov 2026 | 🕛 12:00 CET
👉 Apply now: www.easd.org/academy/acad...
November 2, 2026 at 2:04 PM
🚀 Take your career in #diabetes #research to the next level with the EASD Early Career Academy Mentorship programme. Applications are open for the chance to connect, learn and advance your career with expert mentors.
🗓️ Deadline: 20 Nov 2026 | 🕛 12:00 CET
👉 Apply now: www.easd.org/academy/acad...
🗓️ Deadline: 20 Nov 2026 | 🕛 12:00 CET
👉 Apply now: www.easd.org/academy/acad...
#DiabetedeType2
Introduction plus précoce des iSGLT2 et des aGLP- 1, stratégie davantage personnalisée et objectifs thérapeutiques élargis : le rapport de consensus 2026 de l’EASD et de l’ADA bouscule la stratégie de prise en charge du diabète de type 2 chez l’adulte👉https://monkeylink.co/ce719a
Introduction plus précoce des iSGLT2 et des aGLP- 1, stratégie davantage personnalisée et objectifs thérapeutiques élargis : le rapport de consensus 2026 de l’EASD et de l’ADA bouscule la stratégie de prise en charge du diabète de type 2 chez l’adulte👉https://monkeylink.co/ce719a
Diabète de type 2 : le consensus ADA/EASD rompt avec les anciennes recos
Introduction plus précoce des iSGLT2 et des aGLP- 1, stratégie davantage personnalisée et objectifs thérapeutiques élargis : le rapport de consensus 2026 de l’European Association for the Study of Diabetes (EASD) et de l’American Diabetes Association (ADA) bouscule la stratégie de prise en charge du diabète…
monkeylink.co
November 6, 2026 at 5:00 PM
#DiabetedeType2
Introduction plus précoce des iSGLT2 et des aGLP- 1, stratégie davantage personnalisée et objectifs thérapeutiques élargis : le rapport de consensus 2026 de l’EASD et de l’ADA bouscule la stratégie de prise en charge du diabète de type 2 chez l’adulte👉https://monkeylink.co/ce719a
Introduction plus précoce des iSGLT2 et des aGLP- 1, stratégie davantage personnalisée et objectifs thérapeutiques élargis : le rapport de consensus 2026 de l’EASD et de l’ADA bouscule la stratégie de prise en charge du diabète de type 2 chez l’adulte👉https://monkeylink.co/ce719a
📜 Claim your #EASD2026 CME credits & Certificates of Attendance!
Registered participants of #EASD2026 can now access and download their CME certificates and Certificates of Attendance directly through their personal MyEASD accounts.
📜 👉 Explore more: www.easd.org/annual-meeti...
Registered participants of #EASD2026 can now access and download their CME certificates and Certificates of Attendance directly through their personal MyEASD accounts.
📜 👉 Explore more: www.easd.org/annual-meeti...
November 6, 2026 at 10:00 AM
📜 Claim your #EASD2026 CME credits & Certificates of Attendance!
Registered participants of #EASD2026 can now access and download their CME certificates and Certificates of Attendance directly through their personal MyEASD accounts.
📜 👉 Explore more: www.easd.org/annual-meeti...
Registered participants of #EASD2026 can now access and download their CME certificates and Certificates of Attendance directly through their personal MyEASD accounts.
📜 👉 Explore more: www.easd.org/annual-meeti...
Blog Post: Where is the Love for LADA/Slow Progressing/Early-Stage Type 1 Diabetes? practicaldiabetic.com/2026/11/01/w...
Where is the Love for LADA/Slow Progressing/Early-Stage Type 1 Diabetes?
I was recently at the Annual Meeting for the European Association for the Study of Diabetes, known as “EASD”. This is the largest diabetes conference in the world (this year around 16,000 attended)…
practicaldiabetic.com
November 1, 2026 at 6:46 AM
Blog Post: Where is the Love for LADA/Slow Progressing/Early-Stage Type 1 Diabetes? practicaldiabetic.com/2026/11/01/w...
🎙️In today’s episode, Prof. Jens Juul Holst, recipient of the 2nd EASD Global Impact Prize, discusses the discoveries behind #GLP-1 therapies, their impact on type 2 #diabetes, #obesity & the challenge of making them accessible worldwide.
🎧👉 Listen now: www.easd.org/media-centre...
🎧👉 Listen now: www.easd.org/media-centre...
October 30, 2026 at 9:59 AM
🎙️In today’s episode, Prof. Jens Juul Holst, recipient of the 2nd EASD Global Impact Prize, discusses the discoveries behind #GLP-1 therapies, their impact on type 2 #diabetes, #obesity & the challenge of making them accessible worldwide.
🎧👉 Listen now: www.easd.org/media-centre...
🎧👉 Listen now: www.easd.org/media-centre...
Great science & inspiring international exchange at #EndoBridge2026 in Antalya! The EASD was represented by Prof. Robert Wagner (chair of the EASD Early Career Academy), who delivered a talk & chaired an engaging session.
Congratulations to EndoBridge on a successful congress👏
Congratulations to EndoBridge on a successful congress👏
October 30, 2026 at 2:36 PM
Great science & inspiring international exchange at #EndoBridge2026 in Antalya! The EASD was represented by Prof. Robert Wagner (chair of the EASD Early Career Academy), who delivered a talk & chaired an engaging session.
Congratulations to EndoBridge on a successful congress👏
Congratulations to EndoBridge on a successful congress👏
❓Can #CGM detect beta cell dysfunction before glucose levels rise?
A new study in @diabetologiajnl.bsky.social by Marchiori et al. suggests that CGM-derived measures could help monitor beta cell function in preclinical #T1D.
Read more👉 easd-elearning.eu/news/482/Can...
A new study in @diabetologiajnl.bsky.social by Marchiori et al. suggests that CGM-derived measures could help monitor beta cell function in preclinical #T1D.
Read more👉 easd-elearning.eu/news/482/Can...
October 28, 2026 at 12:42 PM
❓Can #CGM detect beta cell dysfunction before glucose levels rise?
A new study in @diabetologiajnl.bsky.social by Marchiori et al. suggests that CGM-derived measures could help monitor beta cell function in preclinical #T1D.
Read more👉 easd-elearning.eu/news/482/Can...
A new study in @diabetologiajnl.bsky.social by Marchiori et al. suggests that CGM-derived measures could help monitor beta cell function in preclinical #T1D.
Read more👉 easd-elearning.eu/news/482/Can...
（ なおEASDで報告された、2型DM軽度MCIに対する血糖降下薬の「抑制・寛解」作用を比較したRCT “LIGHT-MCI”もぜひ、ご覧ください [拙稿🔗 x.gd/6WAsX ] ）。
【欧州糖尿病学会（EASD）】2型DM例のMCIは早期なら「寛解」も可能。作用には薬剤差も：中規模RCT"LIGHT-MCI"
– 日本医事新報社
2型糖尿病（DM）例では認知機能低下が、非DM例に比べ若年から始まる。しかし早期であれば、血糖降下薬使用により認知機能の改善は可能なようだ。さらにその改善作用は血糖降下薬間で異なる可能性がある。中国で実施されたランダム化比較試験（RCT）"LIGHT-MCI"の結果、明らかになった。9月28日からミラノ（イタリア）で開催された欧州糖尿病学会（EASD）にて、南京大学（中国）のZhou Zhang氏...
x.gd
October 28, 2026 at 10:32 PM
（ なおEASDで報告された、2型DM軽度MCIに対する血糖降下薬の「抑制・寛解」作用を比較したRCT “LIGHT-MCI”もぜひ、ご覧ください [拙稿🔗 x.gd/6WAsX ] ）。
Type 2 diabetes breakthrough as 54% achieve remission in just 6 months
Type 2 diabetes breakthrough as 54% achieve remission in just 6 months
A carefully structured combination of diet and exercise may offer a powerful way to put type 2 diabetes into remission in younger adults. In a new clinical trial, more than half of participants who followed an intensive lifestyle program achieved remission within just six months, compared with only 4% of those receiving standard care. The findings, presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) and published in The Lancet Regional Health Americas, suggest that a low-calorie diet paired with regular exercise could significantly change the course of early-onset type 2 diabetes (EOT2D) (aged under 45 years).
primereports.org
October 31, 2026 at 5:05 AM
Type 2 diabetes breakthrough as 54% achieve remission in just 6 months
🎨 O vindeiro mércores 4 de novembro terá lugar a terceira edición da Xornada USC-EASDRF, unha iniciativa froito do convenio de colaboración entre a Facultade de Humanidades e a Escola de Arte e Superior de Deseño Ramón Falcón 👇
www.usc.gal/gl/xornal/no...
www.usc.gal/gl/xornal/no...
Facultade de Humanidades e EASD Ramón Falcón impulsan unha xornada para reflexionar sobre arte e deseño en Lugo | Universidade de Santiago de Compostela
A terceira edición da Xornada USC-EASDRF desenvólvese o mércores, 4 de novembro, no marco do convenio de colaboración entre a Facultade de Humanidades da USC e a Escola de Arte e Superior de Deseño Ra...
www.usc.gal
October 30, 2026 at 10:29 AM
🎨 O vindeiro mércores 4 de novembro terá lugar a terceira edición da Xornada USC-EASDRF, unha iniciativa froito do convenio de colaboración entre a Facultade de Humanidades e a Escola de Arte e Superior de Deseño Ramón Falcón 👇
www.usc.gal/gl/xornal/no...
www.usc.gal/gl/xornal/no...
🎙️New #Podcast ep.! Today’s episode features 61st EASD Minkowski Prize recipient Zachary Gerhart-Hines (Novo Nordisk Foundation Center for Basic Metabolic Research) explores the NK2 receptor & its potential role in energy expenditure & #metabolichealth.
🎧👉 Listen now: www.easd.org/media-centre...
🎧👉 Listen now: www.easd.org/media-centre...
October 23, 2026 at 9:00 AM
🎙️New #Podcast ep.! Today’s episode features 61st EASD Minkowski Prize recipient Zachary Gerhart-Hines (Novo Nordisk Foundation Center for Basic Metabolic Research) explores the NK2 receptor & its potential role in energy expenditure & #metabolichealth.
🎧👉 Listen now: www.easd.org/media-centre...
🎧👉 Listen now: www.easd.org/media-centre...
📺 Missed the latest EASD Early Career Academy webinar? Recording is available!
The latest #webinar featuring Prof. Fredrik Bäckhed explores the role of the gut microbiota in #cardiometabolic disease and its potential as a target for future therapies.
🎥 Watch now 👉 www.youtube.com/watch?v=xmE8...
The latest #webinar featuring Prof. Fredrik Bäckhed explores the role of the gut microbiota in #cardiometabolic disease and its potential as a target for future therapies.
🎥 Watch now 👉 www.youtube.com/watch?v=xmE8...
October 23, 2026 at 12:02 PM
📺 Missed the latest EASD Early Career Academy webinar? Recording is available!
The latest #webinar featuring Prof. Fredrik Bäckhed explores the role of the gut microbiota in #cardiometabolic disease and its potential as a target for future therapies.
🎥 Watch now 👉 www.youtube.com/watch?v=xmE8...
The latest #webinar featuring Prof. Fredrik Bäckhed explores the role of the gut microbiota in #cardiometabolic disease and its potential as a target for future therapies.
🎥 Watch now 👉 www.youtube.com/watch?v=xmE8...
The EASD Early Career Academy Mentorship Programme is now open for applications, with 10 awards available, supporting the next generation of #diabetes researchers & clinicians through #mentorship.
📅 Application deadline: 20 Nov 2026 | 🕛 12:00 CEST
🔗👉 Apply now: www.easd.org/academy/acad...
📅 Application deadline: 20 Nov 2026 | 🕛 12:00 CEST
🔗👉 Apply now: www.easd.org/academy/acad...
October 22, 2026 at 9:01 AM
The EASD Early Career Academy Mentorship Programme is now open for applications, with 10 awards available, supporting the next generation of #diabetes researchers & clinicians through #mentorship.
📅 Application deadline: 20 Nov 2026 | 🕛 12:00 CEST
🔗👉 Apply now: www.easd.org/academy/acad...
📅 Application deadline: 20 Nov 2026 | 🕛 12:00 CEST
🔗👉 Apply now: www.easd.org/academy/acad...
FIMMA + Maderalia 2026 sitúa la madera en el foco del diseño, el interiorismo y los proyectos contract con el estreno del Ágora y el Espacio EASD
🔗 www.cdicv.com/fimma-madera...
#CDICV #FIMMAMaderalia2026
🔗 www.cdicv.com/fimma-madera...
#CDICV #FIMMAMaderalia2026
October 23, 2026 at 11:37 AM
FIMMA + Maderalia 2026 sitúa la madera en el foco del diseño, el interiorismo y los proyectos contract con el estreno del Ágora y el Espacio EASD
🔗 www.cdicv.com/fimma-madera...
#CDICV #FIMMAMaderalia2026
🔗 www.cdicv.com/fimma-madera...
#CDICV #FIMMAMaderalia2026
📺 Are we doing enough to find #DPN? In a new #ExpertInsights episode with Prof. Rodica Busui (Oregon Health and Science University) suggests how to prevent this #diabetes complication as treatment options are limited still.
🔗👉 Watch here: easd-elearning.eu/episode/382/...
🔗👉 Watch here: easd-elearning.eu/episode/382/...
October 21, 2026 at 12:03 PM
📺 Are we doing enough to find #DPN? In a new #ExpertInsights episode with Prof. Rodica Busui (Oregon Health and Science University) suggests how to prevent this #diabetes complication as treatment options are limited still.
🔗👉 Watch here: easd-elearning.eu/episode/382/...
🔗👉 Watch here: easd-elearning.eu/episode/382/...
（なおオリフォグリプロンのCV転帰改善作用を検討したRCT “ACHIEVE-4” の欧州糖尿病学会 [EASD] 報告については拙稿もご覧いただけると幸いです）。
記事🔗 qr.paps.jp/aLy97
記事🔗 qr.paps.jp/aLy97
【欧州糖尿病学会（EASD）】新規経口GLP-1RA“オルフォグリプロン”の「CV安全性」は確認も「CV保護作用」の有無は不明。「忍容性」に
– 日本医事新報社
オルフォグリプロンは、新たな経口GLP-1受容体作動薬（GLP-1RA）として、わが国でも抗肥満薬として承認申請中である。ではこの薬剤を使えば心血管系（CV）転帰は改善するのだろうか―。 この点を初めて検討したランダム化比較試験（RCT）"ACHIEVE-4"が、9月28日からミラノ（イタリア）で開催された欧州糖尿病学会（EASD）学術集会で報告された。「CV安全性」は確認されたものの、「CV転帰...
qr.paps.jp
October 21, 2026 at 10:07 PM
（なおオリフォグリプロンのCV転帰改善作用を検討したRCT “ACHIEVE-4” の欧州糖尿病学会 [EASD] 報告については拙稿もご覧いただけると幸いです）。
記事🔗 qr.paps.jp/aLy97
記事🔗 qr.paps.jp/aLy97
✨ #EASD2026 by the numbers!
👥 16,000+ registered participants
🌍 Experts from 129 countries
🎥 Hundreds of sessions on demand
Revisit highlights, explore #diabetes research & earn CME credits until 30 Oct 2026 via VMX!
📊 www.easd.org/uploads/EASD...
Thank you for being part of it!💙
👥 16,000+ registered participants
🌍 Experts from 129 countries
🎥 Hundreds of sessions on demand
Revisit highlights, explore #diabetes research & earn CME credits until 30 Oct 2026 via VMX!
📊 www.easd.org/uploads/EASD...
Thank you for being part of it!💙
October 21, 2026 at 9:03 AM
✨ #EASD2026 by the numbers!
👥 16,000+ registered participants
🌍 Experts from 129 countries
🎥 Hundreds of sessions on demand
Revisit highlights, explore #diabetes research & earn CME credits until 30 Oct 2026 via VMX!
📊 www.easd.org/uploads/EASD...
Thank you for being part of it!💙
👥 16,000+ registered participants
🌍 Experts from 129 countries
🎥 Hundreds of sessions on demand
Revisit highlights, explore #diabetes research & earn CME credits until 30 Oct 2026 via VMX!
📊 www.easd.org/uploads/EASD...
Thank you for being part of it!💙
📢 Just 9 days left to apply! EASD members are invited to apply for 2 clinical expert positions on the Guidelines Oversight Committee (GOC), starting in Jan 2027.
📅Deadline: 29 October 2026
👉 Apply now: www.easd.org/guidelines/g...
Help shape evidence-based #Diabetes #care.
📅Deadline: 29 October 2026
👉 Apply now: www.easd.org/guidelines/g...
Help shape evidence-based #Diabetes #care.
October 20, 2026 at 9:09 AM
📢 Just 9 days left to apply! EASD members are invited to apply for 2 clinical expert positions on the Guidelines Oversight Committee (GOC), starting in Jan 2027.
📅Deadline: 29 October 2026
👉 Apply now: www.easd.org/guidelines/g...
Help shape evidence-based #Diabetes #care.
📅Deadline: 29 October 2026
👉 Apply now: www.easd.org/guidelines/g...
Help shape evidence-based #Diabetes #care.
💡 #Studienkompakt: Highlights vom #EASDCongress 2026 aus kardiologischer Sicht! Von der Spritze gegen Bauchfett über Kombi-Präparate bis hin zu dualen & Triple-Agonisten - im Fokus euen Wirkstoffen für die Gewichtsreduktion. Zu den Studien:
➡️ herzmedizin.de/fuer-aerzte-...
#Herzmedizinde #CardioSky
➡️ herzmedizin.de/fuer-aerzte-...
#Herzmedizinde #CardioSky
Studien kompakt: Das EASD-2026-Special
Auswahl von Studien-Highlights des EASD 2026: Die wichtigsten neuen Daten zu Abnehmmitteln kompakt zusammengefasst.
herzmedizin.de
October 21, 2026 at 11:07 AM
💡 #Studienkompakt: Highlights vom #EASDCongress 2026 aus kardiologischer Sicht! Von der Spritze gegen Bauchfett über Kombi-Präparate bis hin zu dualen & Triple-Agonisten - im Fokus euen Wirkstoffen für die Gewichtsreduktion. Zu den Studien:
➡️ herzmedizin.de/fuer-aerzte-...
#Herzmedizinde #CardioSky
➡️ herzmedizin.de/fuer-aerzte-...
#Herzmedizinde #CardioSky